Melhores Linfoma folicular médicos em Israel - TOP-21 médicos

O Dr. Ram Ron é Professor Associado e especialista sénior em hemato-oncologia e transplante de medula óssea no Tel Aviv Sourasky Medical Center.

• Mais de 25 anos de experiência clínica e académica especializada
• Professor Associado na Universidade de Tel Aviv – formação de futuros especialistas
• Focar-se em linfoma, leucemia e mieloma como hematologista
• Especialista em quimioterapia de alta dose e transplantes de medula óssea para cancros do sangue
• Publicação de mais de 90 artigos de investigação em revistas médicas de renome

Realizou centenas de transplantes de células-tronco, um tratamento fundamental para o linfoma folicular, no Centro Médico Sourasky (Ichilov).

• Certificado em hematologia, oncologia e medicina interna
• Escrever mais de 30 artigos científicos e um capítulo de livro didático
• Concluir uma especialização em hematologia e oncologia em Nova York
• Oferecer amplas contribuições acadêmicas para a área médica

A Dra. Ronit El Hasid é uma especialista pediátrica de renome que realizou mais de 300 transplantes de medula óssea e de sangue do cordão umbilical no Hospital Infantil Dana Dwek.

• Chefe do Departamento de Onco-hematologia e Oncologia Pediátrica
• Especialização em transplantes para crianças com cancro do sangue e distúrbios sanguíneos
• Membro da Sociedade Americana de Hematologia
• Membro da Sociedade Israelita de Hemato-oncologia Pediátrica
• Formação no prestigiado Hospital City of Hope, em Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

O Dr. Michael Shapira é especialista em Transplante de Medula Óssea no Sourasky Medical Center (Ichilov), com formação extensiva em instituições de topo.

• Graduado pela Faculdade de Medicina da Universidade Hebraica
• Especializado em medicina interna no Hadassah Medical Center
• Médico sénior em Transplante de Medula Óssea no Hadassah
• Fluente em inglês e hebraico para uma comunicação clara

O Dr. Fredi Aviv possui 31 anos de experiência no tratamento de cancros hematológicos num dos principais hospitais de Israel – o Sourasky Medical Center (Ichilov).

• Onco-hematologista certificado, especializado em cancros do sangue e do sistema linfático.
• Passou toda a sua carreira a trabalhar no Sourasky Medical Center.
• Foco profundo no tratamento do cancro em adultos num ambiente hospitalar universitário de grande relevância.

O Dr. Levin é o diretor do departamento de hematologia e oncologia pediátrica do Sourasky Medical Center em Tel Aviv, com foco em distúrbios sanguíneos e cancros infantis.

• Coordenar o tratamento do cancro ósseo (sarcoma) em crianças com o departamento de Oncologia ortopédica
• Especializar-se em hematologia e oncologia pediátrica, formado no Schneider Children's Medical Center
• Membro da Sociedade Israelita de Hematologia e Oncologia Pediátrica (ISPHO)
• Estudar oncologia no Instituto Ortopédico Rizzoli em Bolonha – um centro líder mundial

O Dr. Kirshner participa ativamente em ensaios clínicos de ponta, incluindo o teste de novos tratamentos para cancros resistentes no Sourasky Medical Center.

• Dupla formação especializada (fellowship) em hematologia e oncologia médica
• Mais de 25 anos de experiência no tratamento de cancros do sangue
• Participar em ensaios clínicos de fase III para terapias avançadas
• Especializar-se em casos de linfoma folicular resistentes ao tratamento

Hematologista premiado diversas vezes e especializado em leucemia linfocítica crónica – o Dr. Herishanu Yair traz experiência baseada em investigação para o atendimento de pacientes no Centro Médico Sourasky.

• Mais de 15 anos de experiência em hematologia
• Recetor de bolsas de prestígio da Israeli Science Foundation e do Weizmann Institute
• Membro das associações de hematologia israelita e americana
• Formado nas principais instituições médicas israelitas
• Investigador publicado em hematologia

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Professor especializado em hematologia e transplante de medula óssea – o Prof. Zuckerman aplica profunda perícia académica no tratamento de doentes no Rambam Medical Center.

• Concentrar-se em cancros hematológicos e oncologia de transplante
• Liderar uma unidade especializada de hematologia e transplantologia
• Professor académico – um líder na investigação e educação médica
• Fazer parte de um centro oncológico multidisciplinar líder em Israel

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

O Dr. Ofer Spielberg é um onco-hematologista dedicado no Assuta Medical Center, especializado em cancros do sangue, como o linfoma folicular.

• Focar-se exclusivamente no diagnóstico e tratamento de neoplasias hematológicas
• Fazer parte de um departamento de oncologia líder em Israel
• Ter experiência em protocolos de tratamento modernos para linfoma

Reconhecida pela Forbes como uma das melhores médicas em 2018 – a Dra. Stepensky realizou mais de 3.500 transplantes de medula óssea.

• 20 anos de experiência em hematologia pediátrica
• Especializada no tratamento de cancros do sangue raros em crianças
• Os doentes e as suas famílias referem-se a ela como “aquela que transplanta a vida”
• Trabalha no Hadassah Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.